Offerings
Products
Distribution Products
Services
- Demat Account
- 3 in 1 Account
Tools & Platforms
Platform
Tools & Calculators
- Open API
- Calculators
Markets
Stocks
F&O
Mutual Funds
ETFs
More
Research
Pricing
Resources

Sector: Pharmaceuticals & Biotechnology

Small Cap

Krebs Biochemicals Share Price

Q: What is the current share price of Krebs Biochemicals & Industries Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Krebs Biochemicals & Industries Ltd. is ₹ 56.1 on the NSE and ₹ 57.849998 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

Q: What is the Market Capitalization of Krebs Biochemicals & Industries Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Krebs Biochemicals & Industries Ltd. is approximately ₹ 121 Cr.

Q: What are the PE and PB ratios for Krebs Biochemicals & Industries Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Krebs Biochemicals & Industries Ltd. is -5.3, and the Price-to-Book (PB) ratio is -0.8.

Q: What is the 52-Week High and Low for Krebs Biochemicals & Industries Ltd.?

Over the past 52 weeks, the highest price reached by Krebs Biochemicals & Industries Ltd. shares was ₹ 113.5, and the lowest price was ₹ 38.33.

Q: Who are the major shareholders of Krebs Biochemicals & Industries Ltd.?

Significant shareholdings in Krebs Biochemicals & Industries Ltd. typically include entities such as: Promoter Public FII Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Krebs Biochemicals & Industries Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Krebs Biochemicals & Industries Ltd. is often compared with other major players such as Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs and Corona Remedies for analysis and benchmarking.

Q: What is the latest dividend information for Krebs Biochemicals & Industries Ltd.?

Krebs Biochemicals & Industries Ltd. last declared a FINAL dividend of ₹ 3 per share for the financial period ending 2005. The record date was set as 2005-09-14, and the payment was/is scheduled around 2005-09-14. For the most current dividend announcements, refer to official company filings.

Krebs Biochemicals & Industries Ltd.

₹56.10

-0.46(-0.81%)

Trade Now

15th May 2026 | 3:01 PM

NSE : KREBSBIO

Open Free Demat Account

Krebs Biochemicals Performance

Price Movement

₹56.10

₹56.00

₹56.17

↘ Today's Low↗ Today's High

1 Year Performance

₹56.10

₹38.33

₹113.50

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹56.17

Low₹56.00

Open at₹56.00

Prev Close₹56.56

Volumes1.78 K

Avg Price₹56.05

Lower Circuit₹53.74

Upper Circuit₹59.38

Historical Performance

3M High₹68.58

3M Low₹38.33

1 Yr High₹113.50

1 Yr Low₹38.33

3 Yr High₹129.07

3 Yr Low₹38.33

5 Yr High₹227.90

5 Yr Low₹38.33

Krebs Biochemicals Fundamentals

Market Cap

Below industry Median

121 Cr.

PE Ratio (TTM)

Negative PE TTM

-5.30

Dividend Yield

Net Profit TTM

6.8% incr over last year

-22.86

Net Profit Growth

6.8% incr over last year

-22.86

PEG Ratio

Negative PEG TTM

-0.80

ROE

Operating Revenue TTM

23.02

Operating Revenue Growth

53% decr over last year

Book Value

Negative Price to Book

-0.80

MFI

MFI is mid-range

54.71

RSI

RSI is mid-range

43.84

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

-0.80

Krebs Biochemicals Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	7.27	4.17	5.48	6.10	11.47
Operating Expense	6.98	6.96	7.57	11.51	16.18
Operating Profit	0.30	-2.79	-2.09	-5.41	-4.72
Depreciation	1.63	1.62	1.60	1.57	1.72
Interest	1.79	1.73	1.65	1.61	1.56
Tax	0	0	0	0.02	0
Net Profit	-3.13	-6.14	-5.32	-8.27	-7.74

Krebs Biochemicals Technicals

Krebs Biochemicals & Industries Ltd. EMA & SMA

₹56.10

-0.46 (-0.81%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹58.5

Day EMA10 ₹59.2

Day EMA12 ₹59.2

Day EMA20 ₹58.9

Day EMA26 ₹58.6

Day EMA50 ₹58

Day EMA100 ₹59.8

Day EMA200 ₹64.8

Krebs Biochemicals Support and Resistance

Resistance

First Resistance₹59.01

Second Resistance₹61.45

Third Resistance₹63.11

Support

First Support₹54.91

Second Support₹53.25

Third Support₹50.81

Technical Indicators

Day RSI43.84

Day MFI54.71

Day ADX17.77

Day Commodity Channel Index-200.50

William-88.06

Day MACD0.67

Day MACD Signal Line1.27

Day ATR2.97

Day ROC125-15.87

Day ROC21-8.57

Krebs Biochemicals Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	72.7	72.7	72.7	72.7	72.7	72.7
FII	0.5	0.5	0.5	0.5	0.5	0.5
DII	0	0	0	0	0	0
Public	26.8	26.8	26.8	26.8	26.8	26.8

Krebs Biochemicals Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	3.83 K	3.83 K	100.00%
Week	1.76 K	1.76 K	100.00%
1 Month	3.24 K	3.53 K	91.75%
6 Month	9.03 K	17.93 K	50.36%

Krebs Biochemicals SWOT Analysis

Strengths5

Weakness10

Opportunity1

Threats0

Upcoming results for Nifty500 companies with previous quarter net profit growth greater than 10% YoY and QoQ

PEG lower than Industry PEG

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

Krebs Biochemicals Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Instrument Type
14 Sep, 2005	3	FINAL	Equity Share
21 Sep, 2004	8	FINAL	Equity Share
18 Sep, 2003	8	FINAL	Equity Share

Krebs Biochemicals Stock Comparison

Financials	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Zim Laboratories Ltd.	Kilitch Drugs(I) Ltd.
Price (₹)	₹485.35	₹6.65	₹130	₹13.40	₹99.60	₹154.25
% Change	0.99%	1.06%	-1.49%	-1.76%	-0.41%	-0.53%
Revenue TTM (₹ Cr)	-	₹83.60	₹282.74	-	₹377.86	₹207.10
Net Profit TTM (₹ Cr)	-	₹-34.95	₹15.30	-	₹6.98	₹26.05
PE TTM	-	-1.60	32.80	-	75.30	20.60
1 Year Return	22.77	559	2.72	46.7	7.37	-24.79
ROCE	28.91	-5.63	-	-	9.61	17.29

Similar Stocks

VENUSREM

Venus Remedies Ltd.

₹ 905.90

-3.39%

LASA

Lasa Supergenerics Ltd.

₹ 7.94

-0.13%

GUJTHEM

Gujarat Themis Biosyn Ltd.

₹ 368.00

-1.34%

MOREPENLAB

Morepen Laboratories Ltd.

₹ 41.91

-2.56%

MEDICAMEQ

Medicamen Biotech Ltd.

₹ 277.50

+2.10%

VINEETLAB

Vineet Laboratories Ltd.

₹ 34.00

-4.39%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 552.10

-3.79%

HIKAL

Hikal Ltd.

₹ 203.40

-2.57%

WANBURY

Wanbury Ltd.

₹ 254.25

-1.66%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 29.95

-1.96%

IOLCP

IOL Chemicals and Pharmaceuticals Ltd.

₹ 105.85

-3.20%

HESTERBIO

Hester Biosciences Ltd.

₹ 1823.00

+4.76%

AAREYDRUGS

Aarey Drugs & Pharmaceuticals Ltd.

₹ 88.06

-3.55%

ALBERTDAVD

Albert David Ltd.

₹ 722.00

+2.57%

KOPRAN

Kopran Ltd.

₹ 155.50

-1.54%

ORTINGLOBE

Ortin Global Ltd.

₹ 14.55

-0.34%

BALPHARMA

Bal Pharma Ltd.

₹ 80.50

+1.96%

JAGSNPHARM

Jagsonpal Pharmaceuticals Ltd.

₹ 206.00

-0.62%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 135.30

-0.44%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2277.20

-3.03%

INDOCO

Indoco Remedies Ltd.

₹ 225.00

-0.24%

AARTIDRUGS

Aarti Drugs Ltd.

₹ 367.00

+1.28%

NATCAPSUQ

Natural Capsules Ltd.

₹ 153.45

-1.53%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 401.70

+0.55%

FAQ's on KREBSBIO

What is the current share price of Krebs Biochemicals & Industries Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Krebs Biochemicals & Industries Ltd. is ₹ 56.1 on the NSE and ₹ 57.849998 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Krebs Biochemicals & Industries Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Krebs Biochemicals & Industries Ltd. is approximately ₹ 121 Cr.

What are the PE and PB ratios for Krebs Biochemicals & Industries Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Krebs Biochemicals & Industries Ltd. is -5.3, and the Price-to-Book (PB) ratio is -0.8.

What is the 52-Week High and Low for Krebs Biochemicals & Industries Ltd.?

Over the past 52 weeks, the highest price reached by Krebs Biochemicals & Industries Ltd. shares was ₹ 113.5, and the lowest price was ₹ 38.33.

Who are the major shareholders of Krebs Biochemicals & Industries Ltd.?

Significant shareholdings in Krebs Biochemicals & Industries Ltd. typically include entities such as:

Promoter
Public
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Krebs Biochemicals & Industries Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Krebs Biochemicals & Industries Ltd. is often compared with other major players such as Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs and Corona Remedies for analysis and benchmarking.

What is the latest dividend information for Krebs Biochemicals & Industries Ltd.?

Krebs Biochemicals & Industries Ltd. last declared a FINAL dividend of ₹ 3 per share for the financial period ending 2005. The record date was set as 2005-09-14, and the payment was/is scheduled around 2005-09-14. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy